Norditropin®

Home Patient Support Company Info Prescribing Information Safety Sign In

Privacy Statement

Thank you for visiting norditropin-us.com, a Novo Nordisk Inc. site. Your privacy is important to us. To better protect your privacy, we provide this notice to explain our online information practices and the choices you can make about the way your information is collected and used at this site.

This web site has been created to provide our visitors information about our company, products, and services.

With respect to our web sites, Novo Nordisk Inc. will collect, store, or use personally identifiable information such as your name, address, telephone number, e-mail address, or other information only when it is voluntarily submitted to us on our sites. This information, when voluntarily submitted, will permit us to respond to requests that you make of us, and from time to time we may refer to your information to better understand your needs and how to improve our web sites, products, and services. We may also use your information to contact you, including providing you with additional support information and special offers from Novo Nordisk Inc. and our business partners.

Novo Nordisk Inc. also collects aggregate or non-personal identifiable information to track data such as the total number of visits to our web sites, the number of visitors to each page of our web sites, and the domain names of our visitors' Internet service providers. We use this information to understand how our visitors use our web sites so that we may make them better. We may also share this information with our parent company, its affiliates, our partners, or other outside companies. No personally identifiable information is disclosed in this process.

Novo Nordisk Inc.'s web sites provide links to other web sites as a service to our visitors. We believe these web sites provide helpful information. However, Novo Nordisk Inc. does not endorse and is not responsible for the content of third-party sites. Nor does Novo Nordisk Inc. have any control over the information that you may choose to provide to these sites. The privacy policy described here does not apply to those sites.

Although we take appropriate measures to safeguard against unauthorized disclosures of information, we cannot assure you that personally identifiable information that we collect will never be disclosed in a manner that is inconsistent with this Privacy Statement. Inadvertent disclosures may result, for example, when third parties misrepresent their identities in asking the site for access to personal identifiable information about themselves for purposes of correcting possible factual errors in the data.

To enhance your experience with our sites, many of our web pages use "cookies." Cookies are text files that we place in your computer's browser to store your preferences. Cookies, by themselves, do not tell us your e-mail address or other personally identifiable information unless you choose to provide this information to us by, for example, registering with one of our sites. However, once you choose to furnish our site(s) with personally identifiable information, this information may be linked to data stored in the cookie.

We use cookies to understand site usage and to improve the content and offerings on our site. For example, we may use cookies to personalize your experience on our web pages (ie, to recognize you by name when you return to our site), save your password in password-protected areas, etc. We also may use cookies to offer you programs, products, or services.

We intend to use the general content of communications, including ideas, inventions, concepts, techniques, and know-how, for other purposes including developing, manufacturing, and/or marketing goods or services.

Indications and Usage

Norditropin® (somatropin [rDNA origin] injection) is used to treat: children who have growth failure because of low or no growth hormone; children who are short (in stature) and who have Noonan syndrome or Turner syndrome; children who are short (in stature) because they were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years; and adults who do not make enough growth hormone.

Important Safety Information

Do not use Norditropin® if: you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems; you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea; you have cancer or other tumors; your healthcare provider tells you that you have certain types of eye problems caused by diabetes; you are a child with closed bone growth plates (epiphyses) or you are allergic to any of the ingredients in the medicine.

Before you take Norditropin®, tell your healthcare provider if you: have diabetes; had cancer or any tumor; have any other medical condition; are pregnant or plan to become pregnant; are breast-feeding or plan to breast-feed.

Norditropin® can cause serious side effects, including: high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems; high risk of death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea; return of tumor or cancerous growths; high blood sugar (hyperglycemia); increase in pressure in the skull (intracranial hypertension); swollen hands and feet due to fluid retention; decrease in thyroid hormone levels; hip and knee pain or a limp in children (slipped capital femoral epiphysis); worsening of pre-existing curvature of the spine (scoliosis); middle ear infection, hearing problems or ear problems in patients with Turner syndrome.

Patients with Noonan syndrome and Turner syndrome should be closely monitored by their doctors as they are more likely to have congenital heart disease.

The most common side effects of Norditropin® include: headaches, muscle pain, joint stiffness, high blood sugar (hyperglycemia), sugar in your urine (glucosuria), swollen hands and feet due to fluid retention, and redness and itching in the area you inject. If you have headaches, eye problems, nausea or vomiting (these may be symptoms of raised pressure in the brain), contact your healthcare provider right away.

Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works so be sure to tell your healthcare provider about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Especially tell your healthcare provider if you take: glucocorticoid medication, thyroid hormone, insulin or other medicine for diabetes, medicines that are metabolized by the liver (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporine), or oral estrogen replacement medicine.

For more information, please click here for complete Norditropin® Prescribing Information.

Norditropin® is a prescription medication.

Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088

Norditropin®, FlexPro® and Norditropin NordiFlex® are registered trademarks of Novo Nordisk Health Care AG. NovoFine® and Novo Nordisk® are registered trademarks and Growth Track Wizard™ is a trademark of Novo Nordisk A/S.
Novo Nordisk Inc., 100 College Road West, Princeton, New Jersey 08540 U.S.A.
© 2011 Novo Nordisk 0411-00002479-1 July 2011